Video
Critical care and COVID-19: Dr. Matt Aldrich
March 30, 2020
Matt Aldrich, MD, medical director of critical care at UCSF Health in San Francisco, speaks about critical care issues in COVID-19.
News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
March 29, 2020
The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients with diabetes and stable disease.
![1]()
Article
Before the COVID-19 surge hits your facility, take steps to boost capacity
March 28, 2020
Communication about resource allocation can ease workforce anxiety amid the coronavirus pandemic.
![1]()
News
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
March 28, 2020
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-world level as we can, as quickly as we can,” said Peter J. Pitts, a former associate commissioner of the FDA.
Article
Wilkie and the VA vs COVID-19: Who’s Winning?
March 27, 2020
As the VA races to address the COVID-19 crisis, Sec. Wilkie faces a battle on multiple fronts.
![1]()
News
Reports suggest possible in utero transmission of novel coronavirus 2019
March 27, 2020
Three neonates whose mothers had COVID-19 had elevated IgM antibody concentrations.
![1]()
Opinion
Two decades of leadership
March 27, 2020
Dr. Larry Wellikson has a deep appreciation of the relationships that he has developed and nurtured.
![1]()
News
Despite strict controls, some infants born to mothers with COVID-19 appear infected
March 27, 2020
But the sources of novel coronavirus 2019 in the neonates’ upper respiratory tracts or anuses likely were maternal in origin.
![1]()
News
Wuhan data link COVID-19 with myocardial damage
March 27, 2020
Findings from 603 COVID-19 patients at two Wuhan hospitals showed a high incidence of myocardial damage that predisposes to higher mortality.
![1]()
News
Rheumatologists seek to reassure amid hydroxychloroquine shortage
March 26, 2020
Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and rheumatologist Michael H. Pillinger discusses the prospects for a new trial of the gout drug colchicine in COVID-19 patients.
